Q2 2023 Heidelberg Pharma AG Earnings Call Transcript
Ladies and gentlemen, thank you, for standing by. Welcome, and thank you for joining Heidelberg Pharma's conference call to discuss 2023 half year financial results and provide a business update.
(Operator Instructions) Please note that today's call is being recorded. (Operator Instructions) The presentation will be followed by a Q&A session where you may ask written or audio questions. Please note that you can ask questions online only. I would now like to turn the call over to Dr. Jan Schmidt-Brand, CEO of Heidelberg Pharma. Please go ahead, Jan.
Thank you, [Regina.] Good afternoon, ladies and gentlemen, and welcome to the Heidelberg Pharma conference call to discuss our results for the first half of 2023 and to provide the business update. My name is Jan Schmidt-Brand, and I am the CEO of the company. Joining me on the call today are my colleagues, Professor Andreas Pahl, Chief Scientific Officer; and Walter Miller, our recently
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |